Capsugel to use NanoGuardian’s anti-counterfeiting tech
NanoGuardian has licensed its NanoEncryption technology to Capsugel, a division of Pfizer, for use as an anti-counterfeiting system on the company’s capsule-based medications.
Capsugel will offer pre-NanoEncrypted capsules to pharma companies, eliminating the capital expenditure needed to install in-house anti-counterfeiting equipment. The company intends to begin supplying the capsules by mid-2010.
Guido Driesen, president and general manager of Capsugel: “After evaluating available security technologies, we chose NanoGuardian as a technology partner because of the sophistication, sustainability and benefits of their NanoEncryption technology.”
NanoGuardian’s technology can be applied directly to capsules, tablets, vial caps and disposable syringes to provide protection from counterfeiting.
